Phacilitate Leaders World

Conference speakers

Jessica Carmen

Jessica Carmen

Consultant, Pullan Consulting

Dr. Carmen is a consultant with Pullan Consulting.  She works with companies across all biotechnology sectors, with an emphasis on cell and gene therapy, helping them shape and execute business strategies. In her previous roles she was responsible for out-licensing an enabling technology for cellular engineering at MaxCyte.  Before that, she was responsible for establishing partnerships with developers of cell-based medicines in order to expand the cell therapy contract manufacturing business at Lonza. Dr Carmen has been instrumental in the establishment of the Standards Coordinating Body for Regenerative Medicines and is a member of the Board of Directors. She is an active member of the Science and Technology Committee of the Alliance for Regenerative Medicine and has served on the Commercialization Committee for the International Society of Cellular Therapy. Dr Carmen earned a Doctorate from the Johns Hopkins University School of Public Health and a Bachelor of Science from the University of Florida.

A little more about Jessica...
In June of 2015 Jessica swam across the Chesapeake Bay (4.4 Miles)

  • Real thinking forward combining experts in the field from manufacturing, regulatory and value vision” – “great network with strong experience and sharing risks & opportunities
    Anne-Virginie Eggimann
    bluebird bio
  • Great program, great people, great venue.
    Klaus Kühlcke
  • Dynamic, interesting and highly interactive event that promotes exchange and networking in highly specialized field of gene therapy.
    Nathalie Clement
    Powell Gene Therapy Center, University of Florida
  • Phacilitate provides a unique forum, bringing together research, process development, and commercial leaders on the cutting edge of cell, gene, and immunotherapy. A great conference for anyone wanting a comprehensive view of the field.
    Dr James Trager
  • It was all business. I’ve never been to an event where over 80% of the conversations I had were constructive to my business objectives.
    Kurt Gielen
    Chemelot Campus B.V.
  • Great way to expand network with global experts in cell and gene therapy who are facing similar challenges.
    Steven Goodman